Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Biohaven Ltd. (BHVN) Financial Statements

Free cash flow over the same period: -$511.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BHVNBiohaven Ltd.Follow BHVN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Research & development437.1373.3795.9635.1467.8
Operating income-567.9-436.1-885.1-745.4-567.4
Pre-tax income-569.8-409.6-845.7-737.4-585.6
Income tax0.4-1.40.71.41.2
Net income-570.3-408.2-846.4-738.8-586.8
Diluted EPS ($)-12.75-5.73-9.28-6.86-3.89
Diluted shares (mn)44.771.291.2107.6—

USD millions · SEC XBRL

Biohaven Ltd. — questions

What is Biohaven Ltd.'s net income?
-$586.8M over the twelve months to 2026-06-30.
What is Biohaven Ltd.'s free cash flow?
-$511.9M over the twelve months to 2026-06-30.
What are Biohaven Ltd.'s diluted earnings per share?
$-3.89 over the twelve months to 2026-06-30.

Every figure on this page comes from Biohaven Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.